ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

2019 American Transplant Congress » Concurrent Session: Kidney Immunosuppression: Novel Regimens and Drug Minimization I

Date: Sunday, June 2, 2019

Time: 4:30pm-6:00pm

Location: Veterans Auditorium

Session Type: Concurrent Session

Meeting: 2019 American Transplant Congress

4:30pm-4:42pm
Antirejection Efficacy in De Novo Renal Transplant Recipients Receiving Everolimus with a Reduced-Exposure Calcineurin Inhibitor-Based Regimen: 24-Month Results from the TRANSFORM Study

H. Tedesco Silva1, F. Citterio1, M. Henry1, T. R. Srinivas1, Y. Watarai1, S. Steinberg1, N. Basic-Jukic1, V. D. Garcia1, E. Mor1, V. R. Peddi1, P. Narvekar2, M. P. Hernandez Gutierrez2, P. Bernhardt2, J. Pascual1

4:42pm-4:54pm
Efficacy and Safety Outcomes with De Novo Use of Everolimus-Based Regimen in Renal Transplant Recipients with Delayed Graft Function from the TRANSFORM Study

S. Chadban1, F. Oppenheimer1, F. Citterio1, O. Witzke1, V. D. Garcia1, A. Gutierrez-Dalmau1, P. Narvekar2, M. P. Hernandez Gutierrez2, P. Bernhardt2, A. Wiseman1

4:54pm-5:06pm
The Use of mTOR Inhibitors Prevents Acute Cellular Rejection in Kidney Transplantation on Belatacept Therapy

J. Shoji, J. C. Leung, Q. Tang, J. P. Roberts, F. Vincenti

5:06pm-5:18pm
Early Steroid Withdrawal in African American Deceased Donor Renal Transplant Recipients with Alemtuzumab Induction: Is Graft Loss on the Horizon?

R. Lynn, B. Ravichandran, T. Sparkes, A. Haririan, J. Bromberg, J. Casale

5:18pm-5:30pm
Early Outcomes Comparing Two Steroid-Avoidance Protocols in Pediatric Renal Transplantation

D. Puliyanda1, H. Pizzo1, N. Rodig2, M. Somers2

5:30pm-5:42pm
Impact of Steroid-Free Protocol on Incidence of Posttransplantation Diabetes Mellitus: A Prospective, Randomized, Multicenter, Open-Label, Controlled Trial in Renal Transplant Recipients

J. Ekberg1, S. Baid-Agrawal1, B. Jespersen2, R. Källén3, E. Rafael3, K. Skov2, P. Lindnér1

5:42pm-5:54pm
What’s in a High Dose? An Analysis of Tacrolimus Pharmacokinetic Parameters in Rapid Metabolizers

P. West-Thielke1, A. Maldonado2, S. J. Patel3, D. R. Stevens3, U. Meier-Kriesche3, D. Brennan4

« View all sessions from the 2019 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences